Bioventix PLC
BVXP.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | £13,116 | £13,607 | £12,816 | £11,719 |
| % Growth | -3.6% | 6.2% | 9.4% | – |
| Cost of Goods Sold | £1,199 | £926 | £958 | £854 |
| Gross Profit | £11,917 | £12,681 | £11,859 | £10,865 |
| % Margin | 90.9% | 93.2% | 92.5% | 92.7% |
| R&D Expenses | £1,486 | £999 | £1,201 | £975 |
| G&A Expenses | £2,051 | £1,995 | £1,769 | £1,605 |
| SG&A Expenses | £2,051 | £971 | £612 | £732 |
| Sales & Mktg Exp. | £0 | -£1,024 | -£1,157 | -£874 |
| Other Operating Expenses | -£1,524 | £127 | £0 | £0 |
| Operating Expenses | £2,013 | £2,097 | £1,814 | £1,707 |
| Operating Income | £9,904 | £10,597 | £10,045 | £9,274 |
| % Margin | 75.5% | 77.9% | 78.4% | 79.1% |
| Other Income/Exp. Net | £192 | £19 | £101 | £5 |
| Pre-Tax Income | £10,096 | £10,574 | £10,109 | £9,256 |
| Tax Expense | £2,511 | £2,477 | £1,737 | £1,604 |
| Net Income | £7,584 | £8,097 | £8,372 | £7,674 |
| % Margin | 57.8% | 59.5% | 65.3% | 65.5% |
| EPS | 1.45 | 1.55 | 1.61 | 1.47 |
| % Growth | -6.5% | -3.7% | 9.5% | – |
| EPS Diluted | 1.43 | 1.53 | 1.58 | 1.46 |
| Weighted Avg Shares Out | 5,221 | 5,220 | 5,212 | 5,209 |
| Weighted Avg Shares Out Dil | 5,293 | 5,297 | 5,290 | 5,260 |
| Supplemental Information | – | – | – | – |
| Interest Income | £192 | £202 | £101 | £5 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £93 | £114 | £129 | £143 |
| EBITDA | £10,166 | £10,740 | £10,199 | £9,422 |
| % Margin | 77.5% | 78.9% | 79.6% | 80.4% |